Intravitreal PRN ranibizumab treatment for macular edema due to branch retinal vein occlusion

Creative Commons License

ÇAKMAK H. B., Arikan Yorgun M., TOKLU Y., Mutlu M.

TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.47, sa.1, ss.40-46, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 47 Sayı: 1
  • Basım Tarihi: 2017
  • Doi Numarası: 10.3906/sag-1509-39
  • Dergi Adı: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.40-46
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Background/aim: To evaluate the effect of intravitreal pro re nata (PRN) ranibizumab treatment from the start on the best-corrected visual acuity (BCVA) and the central retinal thickness (CRT) in macular edema (ME) due to branch retinal vein occlusion (BRVO).